Bacteriophage Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Targeted Bacteria (Escherichia coli, Streptococcus, Pseudomonas, Staphylococcus, Salmonella, Others); Route of Administration (Oral, Topical, Parenteral); Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others); End User (Hospitals & Clinics, Academic Research Organizations & Institutes, Others), and Geography
Bacteriophage therapy is also known as phage therapy. It needs viruses for the medication of bacterial infections. Bacterial viruses are called bacteriophages or phages. They combat bacteria; phages are safe to animals, plants, and humans. Bacteriophages are supposed to be natural antagonists of bacteria. Bacteriophages are found in soil, water, sewage, and other places where bacteria are exposed. Phage therapy is widely being reviewed as an option for antibiotics. Therefore, phage therapy is the remedial use of lytic bacteriophages for managing pathogenic bacterial infections.
The bacteriophage therapy market is driving due to the rising prevalence of drug-resistant infections, increasing research, and the development of products. However, the high cost of bacteriophage therapy and the shortage of skilled professionals are expected to hamper the growth of the global bacteriophage therapy market. Moreover, growing strategic alliances by market players are anticipated to drive demand for the growth of the market for bacteriophage therapy.
The "Bacteriophage Therapy Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of bacteriophage therapy market with detailed market segmentation by targeted bacteria, route of administration, application and end user. The bacteriophage therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in bacteriophage therapy market and offers key trends and opportunities in the market.
The bacteriophage therapy market is segmented on the basis of targeted bacteria, route of administration, application and end user. Based on targeted bacteria, the market is segmented as Escherichia coli, Streptococcus, Pseudomonas, Staphylococcus, Salmonella, others. On the basis of route of administration, the market is categorized as oral, topical, parenteral. On the basis of application, the market is categorized as diagnostic, antimicrobial drug discovery, veterinary medicines, and others. On the basis of end user, the market is categorized as hospitals & clinics, academic research organizations & institutes, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the bacteriophage therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bacteriophage therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting bacteriophage therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bacteriophage therapy market in these regions.
Get more information on this report :
The report covers key developments in the bacteriophage therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bacteriophage therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for bacteriophage therapy in the global market. Below mentioned is the list of few companies engaged in the bacteriophage therapy market.
The report also includes the profiles of key players in bacteriophage therapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Armata Pharmaceuticals, Inc.
Eliava Bio Preparations LTD
LOCUS BIOSCIENCES, INC.
Phage International, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Armata Pharmaceuticals, Inc.
2. Intralytix, Inc.
3. Pherecydes Pharma
4. Eliava Bio Preparations LTD
6. LOCUS BIOSCIENCES, INC.
7. Fixed-Phage Limited
8. Phage International, Inc.
9. iNtODEWORLD, Inc.
10. InnoPhage, Ltd